Abstract
Introduction

Autoimmune blistering diseases are acquired chronic diseases associated with an immune response directed to structural proteins that maintain cell-cell and cell-matrix adhesion in the skin and mucous
• Introduction
membranes. Based on clinical, histopathological, and immunopathological criteria, autoimmune bullous diseases are classified into four major groups: pemphigus diseases and pemphigoid diseases, epidermolysis bullosa acquisita, and dermatitis herpetiformis Duhring (Table 1). The first group of diseases includes life-threatening blistering diseases characterized by intraepidermal blister formation due to the loss of adhesion of keratinocytes and is associated with autoantibodies to the intercellular junctions of keratinocytes. The remainder of these diseases are characterized by sub-epidermal blisters caused by the loss of attachment of basal keratinocytes to the underlying basement membrane and are associated with deposition of immunoreactants at the dermal-epidermal junction. Target antigens of autoantibodies have been identified for the majority of autoimmune blistering diseases (
.
Pemphigus diseases
Pemphigus (from the Greek pemphix meaning bubble or blister) designates a group of life-threatening autoimmune blistering diseases characterized by intraepithelial blister formation [3] [4] [5] . The molecular basis for blister formation is a loss of adhesion between epidermal cells (acantholysis) caused by circulating autoantibodies directed against intercellular adhesion structures of keratinocytes [6] [7] [8] [9] [6] [7] [8] [9] .
The direct immunofluorescence microscopy of patients' perilesional skin reveals intercellular deposition of immunoreactants. Circulating serum autoantibodies can be detected by indirect immunofluorescence microscopy using human skin or other senzitive substrates, most commonly monkey esophagus (Fig. 2) . Autoantibodies in patients with pemphigus vulgaris and foliaceus target different keratinocyte proteins, including desmogleins 1 [10] , 3 [11, 12] and 4 [13] , annexins [14] and acetylcholine receptors [15] . Cloning of desmoglein 1 and 3 cDNA enabled the development of a sensitive and specific ELISA and extensive characterization of the autoreactivity against these antigens in pemphigus patients [16] . Serum levels of autoantibodies detected by ELISA strongly correlate with disease activity in pemphigus patients [16, 17] [18] . Subsequently, the pathogenicity of autoantibodies from patients with sporadic or endemic pemphigus foliaceus (fogo selvagem) was demonstrated using a similar approach [19, 20] . [14, 15] . [10, [26] [27] [28] .
Pemphigus vulgaris
Pemphigus foliaceus
Pemphigus variants Pemphigus herpetiformis
Pemphigus herpetiformis is a form of pemphigus resembling dermatitis herpetiformis in its early-phase [29] [30] . The condition usually evolves into classical pemphigus foliaceus, and rarely into pemphigus vulgaris.
Fig. 3 Serological tests used for the diagnosis of paraneoplatic pemphigus. (A) Serum autoantibodies from a patient with paraneoplastic pemphigus bind to rat bladder urothelium, as revealed by indirect immunofluorescence microscopy (magnification, ϫ200). (B) An extract of cultured keratinocytes was fractionated by 7.5% SDS-PAGE, transferred to nitrocellulose, and incubated with paraneoplastic pemphigus serum (lane 1) and with normal human serum (lane 2). Paraneoplastic pemphigus serum reacts with envoplakin (210 kD; upper arrow) and periplakin (190 kD; lower arrow), while control serum shows no specific reactivity. Molecular weight markers are depicted on the right side of the panel.
Pemphigus erythematosus
Pemphigus erythematosus (Senear- [6, 31] . In addition, in some of these patients, deposits of immunoreactants along the skin basement membrane zone and serum antinuclear antibodies may be found suggesting an association with lupus erythematosus [2] .
Drug-induced pemphigus
Although there are sporadic case reports of pemphigus in association with the use of certain medication, the association with sulfhydril drugs, including D-penicillamin and captopril, is the most significant [32] . [33] . [34] [35] [36] [37] [2, [40] [41] [42] (Fig. 3B ). dermal-epidermal separation in cryosections of human skin [59] and (3) serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid [60] .
Clinically, superficial pemphigus (including erythematosus) is more common than pemphigus vulgaris in sulfhydril-drugs treated patients. Though the autoantigen(s) of the drug-induced pemphigus have not yet been thoroughly characterized, autoantibodies against desmogleins were found in a subgroup of patients
Paraneoplastic pemphigus
Paraneoplastic pemphigus is usually characterized by painful lesions of the mucosal surfaces and erythema multiforme-like lesions of palms and soles
IgA pemphigus
The histopathological examination of bullous pemphigoid patients' lesional skin reveals a sub-epidermal blister with a rich inflammatory infiltrate consisting predominantly of eosinophils and neutrophils [61] . The direct immunofluorescence microscopy reveals linear deposits of C3 and/or IgG along the dermal-epidermal junction (Fig. 4A) . By indirect immunofluorescence microscopy, circulating autoantibodies binding to the skin basement membrane zone are detected in serum of bullous pemphigoid patients [62] . The use of 1 M NaCl-split normal human skin as a substrate increases the sensitivity of the indirect immunofluorescent analysis facilitating the detection of autoantibodies in 90% of bullous pemphigoid patients [63, 64] (Fig. 4B) . However, indirect immunofluorescence microscopy does not allow differentiating the molecular target of autoantibodies. Therefore, molecular techniques like immunoblot (Fig. 5A ) and immunoprecipitation assays are used to demonstrate the specificity of bullous pemphigoid autoantibodies [53, 65] . In addition, highly sensitive ELISAs for detecting circulating autoantibodies to recombinant BP180 have been developed [66] [67] [68] [69] [70] (Fig. 5B) commercially available by Medical Biological Laboratories (Nagoya, Japan) [69, 71] . [81, 84, 85] .
Pemphigoid gestationis
Cutaneous manifestations in patients with linear IgA disease include erythematous papules, urticarial plaques or vesicobullous eruptions. Lesions may appear as tense arciform bullae in a 'cluster of jewels' configuration or, less
Fig. 6 Circulating autoantibodies from patients with linear IgA disease react with LAD-1 and LABD97. Concentrated supernatant of cultured keratinocytes was separated by 10% SDS-PAGE, transferred to nitrocellulose, and incubated with sera from patients with linear IgA disease (LAD; lanes 1-2), bullous pemphigoid (BP; lane 3), and healthy controls (NHS; lane 4). Subsequently, the nitrocellulose strips were incubated with HRP-labeled secondary antibodies to human IgA. Autoantibodies from patients with linear IgA disease react with both proteolytic fragments of BP180, LAD-1 (120 kD; lanes 1-2, upper arrow) and LABD97 (97 kD; lane 1, lower arrow). Serum autoantibodies from a patient with bullous pemphigoid recognize LAD-1 (lane 3). Control serum shows no specific reactivity (lane 4). Molecular weight markers are depicted on the right side of the panel.
commonly, as grouped papulovesicles [86] .
Involvement of mucosal surface is present in the majority (60-80%) of both children and adults with linear
IgA disease [87, 88] . [90, 91] . Based on biochemical studies and peptide sequence analyses, it now appears that LABD97 and LAD-1 are generated as proteolytic cleavage products of the BP180 ectodomain [92] [93] [94] [95] . [160] . [2] (Fig. 6 ). [2] (Fig. 7) . About 30% of patients with the clinical phenotype mucous membrane pemphigoid reveal autoantibodies binding to the dermal side of the 1 M NaCl-split skin specific for laminin 5 [97, 98] . [99, 100] . Autoantibodies in mucous membrane pemphigoid target epitopes on both extra-and intracellular domains of BP180 [98] . In addition to the reactivity to BP180, serum autoantibodies that bind to the roof of the 1 M NaCl-split skin have been shown to target the ␤4 chain of ␣ 6 ␤ 4 integrin in patients with ocular mucous membrane pemphigoid [101, 102] . These autoantibodies induced sub-epithelial cleavage in human conjunctiva cultured in vitro [103] and human buccal mucosa [104] . Rabbit antibodies generated against the immunodominant epitopes on ␤4 integrin also induced bazal membrane zone separation in an in vitro buccal mucosa model [104] . Moreover [106] . While the exact identity of p200 remains unknown, it has been demonstrated to be immunologically and biochemically distinct from all major autoantigens of the dermal-epidermal junction, including bullous pemphigoid antigens 180 and 230, laminin 1, 5 and 6, ␣6␤4 integrin, and type VII collagen [107, 108] . Clinically, most reported cases present with tense blisters as well as urticarial papules and plaques, closely resembling bullous pemphigoid or inflammatory epidermolysis bullosa acquisita [109, 110] [107, 109] .
Different target antigens of the lamina lucida-type of linear IgA disease have been reported, including a 97 kD protein (LABD97) extracted from epidermis [89] and a 120 kD polypeptide (LAD-1) secreted into the medium of cultured human keratinocytes
Histologically, sub-epidermal blisters and a rich inflammatory infiltrate consisting of large numbers of neutrophils, often accumulating at the papillary tips,
Fig. 7 Serological tests used for the diagnosis of mucous membrane pemhigoid. (A) Serum autoantibodies from most patients with mucous membrane pemhigoid bind to the epidermal side of the salt-split skin by indirect immunofluorescence microscopy (magnification, ϫ100). (B) In a subgroup of patients with mucous membrane pemhigoid, circulating autoantibodies show a dermal binding pattern by indirect immunofluorescence microscopy (magnification, ϫ100). (C) Extracellular matrix of cultured keratinocytes was separated by 7.5% SDS-PAGE, transferred to nitrocellulose, and incubated with mucous membrane pemhigoid and control sera
Autoantibodies from mucous membrane pemhigoid patients react with non-processed (200 kD; lane 1, upper closed circle) and processed (165 kD; lane 1, middle closed circle, and lane 2, upper closed circles) forms of the ␣3-chain of laminin 5, as well as with the ␤2-chain (155 kD; lane 1 and 2, lower closed circles) of laminin 5. Control serum shows no specific reactivity (lane 3). Molecular weight
Mucous membrane pemphigoid
The pathogenic relevance of anti-laminin 5 antibodies was demonstrated by the passive transfer of antilaminin five antibodies into mice, inducing a sub-epidermal blistering disease
Anti-p200 pemphigoid
Anti-p200 pemphigoid is a recently defined autoimmune sub-epidermal blistering disease characterized by circulating and tissue-bound autoantibodies to a 200-kD protein (p200) at the interface between lamina lucida and lamina densa of the dermal-epidermal junction
Epidermolysis bullosa acquisita
Epidermolysis bullosa acquisita is a chronic blistering disease of skin and mucous membranes characterized by sub-epidermal blisters and tissue-bound and circulating autoantibodies to the dermal-epidermal junction. Type VII collagen, the main constituent of anchoring fibrils, was identified as the autoantigen of epidermolysis bullosa acquisita [111, 112] .
The pathogenic relevance of antibodies against type VII collagen is supported by compelling evidence: (1) Epidermolysis bullosa acquisita autoantibodies were shown to recruit and activate leucocytes ex vivo resulting in dermal-epidermal separation in cryosections of human skin [113, 114] . (2) Antibodies against type VII collagen induce sub-epidermal blisters when passively transferred into mice [115, 116] . (3) Immunization with recombinant autologous type VII collagen induces an autoimmune response to this protein resulting in a blistering phenotype closely resembling human epidermolysis bullosa acquisita [117, 118] .
Epidermolysis bullosa acquisita is a clinically heterogeneous disease, which may present with an inflammatory or non-inflammatory phenotype. The first cases of a blistering disease with adult onset and features highly reminiscent of hereditary dystrophic epidermolysis bullosa were reported by Elliott more than 100 years ago [119] . The mechanobullous, noninflammatory form of epidermolysis bullosa acquisita, was defined in 1971 and is characterized by extreme skin fragility, trauma-induced blisters and erosions localized to the extensor skin surface, healing with scars and milia [120] . In addition to the mechanobullous variant, several inflammatory subtypes of epidermolysis bullosa acquisita were described, clinically mimicking bullous pemphigoid, linear IgA disease, or mucous membrane pemphigoid [121] [122] [123] . Certain epidermolysis bullosa acquisita patients present with inflammatory phenotype at the onset of the disease with overlapping or later evolving mechanobullous features [123, 124] . The disease typically affects adults but juvenile cases were also reported [125] [126] [127] . Epidermolysis bullosa acquisita is a rare disease occurring in approximately 5% of unselected patients with basement membrane zone antibodies [128] .
Histopathological examination of lesional biopsy reveals sub-epidermal blisters associated with various degrees of inflammatory infiltrate in the upper dermis, usually concordant with the clinical presentation [129] . The classical presentation shows little inflammatory infiltrate within the dermis as opposed to the inflammatory type [130] . Ultrastructurally, the cleavage plane can be localized within the lamina lucida or sub-lamina densa regions of the dermal-epidermal junction [131] . The cleavage within the lamina lucida seems to be associated with presence of an inflammatory infiltrate rich in polymorphonuclear neutrophils [131] .
Fig. 8 Serum autoantibodies from patients with epidermolysis bullosa acquisita react with both full-length type VII collagen and with its immunodominant domain. Dermal extracts (DE) and a recombinant form of the non-collagenous (NC
The disease is immunopathologically characterized by deposition of immunoreactants at the dermal-epidermal junction by direct immunofluorescence microscopy. The IgG and/or C3 deposits were shown to localize to the sub-lamina densa region of dermal-epidermal junction by direct immunoelectron microscopy [132] . Indirect immunofluorescence microscopy on 1M NaCl split-skin evidence autoantibodies to the dermal versant of the dermal-epidermal junction in serum of epidermolysis bullosa acquisita patients [63] , which label the sub-lamina densa zone by indirect immunoelectronmicroscopy [133] . Epidermolysis bullosa acquisita serum autoantibodies recognize the 290 kD type VII collagen, or its immunodominant region, the non-collagenous domain 1, by immunoblotting with dermal extracts [111] (Fig. 8) and immunoprecipitation with keratinocyte and fibroblast extracts [134] . A sensitive ELISA for the detection of autoantibodies to type VII collagen using recombinant protein is also available [135] .
Dermatitis herpetiformis Duhring
Dermatitis herpetiformis is an intensely pruritic, chronic autoimmune blistering skin disease characterized by granular IgA deposits in the papillary dermis and association with celiac disease [136, 137] . The disease was initially described by Louis Duhring, which coined the term dermatitis herpetiformis in 1884 [138] . Later studies found small-bowel changes suggestive of celiac disease in the majority of patients with dermatitis herpetiformis [139] [140] [141] . Subsequently, both diseases were shown to be associated with certain HLA haplotypes, especially with DR3 and DQw2 [142] . A major advance was the detection of IgA deposition in the papillary dermis of patients with dermatitis herpetiformis [143, 144] . Clinically, an intense pruritic rash, symmetrically distributed on the extensor surfaces including elbows, knees, buttocks, and scalp, characterizes patients with dermatitis herpetiformis. The rash is polymorphic with small blisters. These are, however, often eroded and crusted because of intense itch and scratching [145, 146] [109] . Ultrastructural studies have shown that IgA deposits are localized to the papillary dermis [147] . However, the ultrastructural localization of blister has been shown to be within the lamina lucida of the dermal-epidermal junction [148, 149] .
Direct immunofluorescence microscopy of a biopsy of normal-appearing skin adjacent to an active lesion reveals granular IgA deposits in the dermal papillae [144, 150, 151] (Fig. 9A) [153, 154] (Fig. 9B) 
